INTRODUCTION
Increasing numbers of biopharmaceutical studies require potent and rapid expression systems in order to rapidly validate potential therapeutically important protein targets. Mammalian cell systems are of particular interest, since they ensure proper posttranslational modification of expressed proteins. Recently, several members of the alphaviral group, including Sindbis (SIN) and Semliki Forest (SFV) viruses have received considerable attention as vehicles for transient expression of proteins (1) (2) (3) . Alphaviruses are positive-strand RNA viruses that replicate entirely in the cytoplasm without DNA intermediates (4) . Nevertheless, DNA-based SIN vectors have been developed by introducing a eukaryotic promoter upstream of the alphavirus replicon (5) (6) (7) . In these DNA-RNA layered vectors, the structural proteins expressed from the viral subgenomic promoter are substituted with a gene of interest. The viral genomic RNA is produced in the nucleus and transported to the cytoplasm where it is replicated by the viral nonstructural proteins, as occurs during a natural infection.
We previously reported the generation of a SIN-based temperatureinducible noncytopathic DNA-RNA layered vector termed CytTs (8) . In this vector system, viral genomic RNA is constantly produced in the nucleus and transported to the cytoplasm. However, the subsequent synthesis of negativestrand RNA, which serves as a template for the production of genomic RNA and a high level of subgenomic RNA coding for the protein of interest, is catalyzed by the mutated viral replicase only at permissive temperatures (<35°C). CytTs has been shown to display very tight repression of gene expression at nonpermissive temperature and has been successfully used to generate stable cell lines that express various proteins (8) (9) (10) (11) . Importantly, due to the tight regulation of gene expression, CytTs vector allows for the inducible production of a high level of toxic proteins (8) . Yet, like other stable expression systems, CytTs relies on the chromosomal integration of the plasmid into the host cell genome. Due to the random integration and silencing of integrated vector copies, many individual clones need to be screened to get a high producer cell clone. Hence, although the expression system is particularly valuable for the expression of toxic proteins, the generation of a high producer cell clone is still timeconsuming and labor-intensive.
To circumvent the need for the tedious process of clonal selection, considerable efforts have been made to construct vectors based on episomally replicating DNA viruses. In particular, vectors derived from the EpsteinBarr virus (EBV) have been shown to be stably maintained in different human and other primate cell lines over extended time periods (12) (13) (14) . In fact, only two EBV components are needed to stably maintain recombinant plasmids in dividing cells: (i) the cisacting origin of DNA replication (OriP) and (ii) the trans-acting EBV-encoded nuclear antigen (EBNA1) (12, 15) . Different expression vectors containing the minimal elements from EBV have been generated and successfully used for production of recombinant proteins (16) (17) (18) .
In this study we describe the generation of a hybrid vector that can replicate episomally like traditional EBV vectors but also has all the advantages of the SIN-derived CytTs vector. Our novel SIN/EBV hybrid vector allowed the rapid generation of semistable cell populations that inducibly express high levels of a desired protein.
MATERIALS AND METHODS

Constructs
CytTs constructs used in this study are derived from ecCytTs, which has been previously described (11 
Cells and Transfections
293-EBNA (Invitrogen) and baby hamster kidney (BHK) cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics/antimycotics. All transfections were performed using Lipofectamine™ 2000 (Invitrogen) according to the manufacturer's recommendations. One day after transfection, cells were split in the presence of puromycin (1 μg/mL for 293-EBNA and 5 μg/mL for BHK cells). Resistant cell pools were further expanded and maintained under selective pressure. Once the cells had reached confluence, the medium was changed, and the plates were shifted to 29°C for the induction of gene expression.
Fermentation
293-EBNA cells were first adapted to serum-free growth using 293SFMII medium (Invitrogen) according to the manufacturer's recommendations. For transfection purposes, cells were propagated in DMEM supplemented with 10% fetal calf serum (FCS). Resistant cells were expanded in serum-free 293 SFMII medium supplemented with 4 mM L-glutamine, 0.5 g/L pluronic F68 (Sigma, Buchs, Switzerland), and 1 μg/mL puromycin (Sigma). Cells were further expanded in a spinner flask with a 1:1 mix of 293SFMII and InVitrus™ VP-6 medium (Cell Culture Technologies, Gravesano, Switzerland). Cells were then collected by centrifugation, resuspended at a density of 0.44 × 10 6 cells/mL in 200 mL InVitrus VP-6 medium, and used to inoculate a 1-L disposable bioreactor chamber (Cellbag 2L; Wave Biotech AG, Tagelswangen, Switzerland). The culture volume was gradually expanded over 8 days until a final volume of 1 L was reached. At a cell density of 0.9 × 10 6 cells/mL, the perfusion run was started with two medium exchanges per day. After 6 days of perfusion fermentation at a cell density of 3.4 × 10 6 cells/mL, the bioreactor temperature was decreased to 29°C for induction of protein expression.
Determination of INFβ, EPO, and SEAP Concentrations in Supernatants
IFNβ and EPO concentrations were determined in cell culture supernatants using enzyme-linked immunosorbent assays (ELISAs) from TFB (Tokyo, Japan) and R&D Systems (Minneapolis, MN, USA) according to the manufacturers' recommendations. SEAP concentrations were measured using an enzymatic activity assay as described earlier (19) . 
RESULTS AND DISCUSSION
To generate a CytTs vector that can replicate episomally, the EBV-derived mini-replicon, consisting of the EBNA1 gene and OriP, was inserted into CytTs vectors as shown in Figure 1 . The EBV mini-replicon was inserted into several vectors expressing either GFP, INFβ, SEAP, or EPO. The constructs were named CytTs-GFP-OPE, CytTs-SEAP-OPE, CytTs-INFβ-OPE, and CytTs-EPO-OPE respectively.
In a first set of experiments, BHK cells were transfected with CytTs-GFP-OPE. One day after transfection, cells were passaged under selective pressure. Once all nontransfected cells had died, resistant cell populations were expanded and analyzed for protein production at permissive (29°C) and nonpermissive (37°C) temperatures. After 2 days, cells of the different samples were harvested and analyzed by fluorescence-activated cell sorting (FACS). At nonpermissive temperature, <0.4% of the cells turned out to be GFP positive. In contrast, virtually all cells (93%) showed GFP expression upon induction at 29°C. It is important to note that the percentage of GFP positive cells achieved here with CytTs-GFP-OPE was higher than the percentage previously observed in a detailed analysis of stable CytTs-GFP cell clones. The expression of the latter ranged from 0.5% to 80% GFP positive cells upon induction (11) . Hence, the hybrid SIN/EBV expression vector allows the generation of cell populations that inducibly expresses high levels of protein.
We further tested the SIN/EBV system with two secreted proteins. BHK cells were transfected with either CytTs-SEAP-OPE or CytTs-IFNβ-OPE and processed as described above. Resistant cell populations were analyzed for protein production at permissive and nonpermissive temperatures. Tissue culture supernatants were harvested at different time points after induction, and the quantity of produced INFβ and SEAP was determined. As shown in Figure 2 , the highest levels of INFβ (10 6 IU/mL, 5 mg/mL) were reached after 7 days of production. SEAP levels were even higher and reached a concentration of 53 mg/L after 9 days of induction. Both proteins were not detectable in cultures kept at nonpermissive temperatures.
The expression levels achieved with the episomally replicating vector expressing INFβ were roughly six times higher then the ones obtained in previous experiments with a high producer CytTs-IFNβ cell clone in adherent cultures and were comparable to the productivities achieved with the same clone in spinner flask cultures after 12 days of induction (10) .
The results obtained so far establish, first, that high productivities are achieved with the hybrid SIN/EBV vectors and, second, that the tight regulation of gene expression is maintained under these transient expression conditions.
In a next set of experiments, we tested whether this vector may be useful for large-scale protein production. For this purpose, the novel vector was tested in 293-EBNA cells, which are routinely used for fermentation processes and have been shown to support EBVmediated DNA replication (16) . Initial tests were done on adherent cells in 75 cm 2 T flasks. 293-EBNA cells were transfected with CytTs-EPO-OPE and passaged under puromycin selection. Resistant cell populations were then analyzed for protein production at permissive and nonpermissive temperatures. Aliquots of the supernatants were harvested after 4 and 8 days of production and analyzed by ELISA. EPO concentration was 2.6 mg/L after 4 days of induction and 3.9 mg/L after 8 days of induction. At nonpermissive temperatures, EPO concentration in tissue culture supernatants was below the detection limit throughout the experiment. Taken together, these results show that good productivities are achieved in 293 cells and that the expression is still tightly regulated with the CytTs-OPE vector.
In order to test whether SIN/EBV vectors are stably maintained, selected cell populations were used to run a fermentation process. Serum-free adapted 293-EBNA cells were transfected with pCytTS-EPO-OPE and passaged under selective pressure. Resistant cell populations were first propagated in serum-free medium in a spinner flask and used to inoculate a 1-L disposable bioreactor chamber. The volume was gradually increased to the final volume of 1 L, and then cell density was further augmented by a perfusion phase. At a density of 3.4 × 10 6 cells/mL, the bioreactor temperature was reduced to 29°C to induce expression. Highest EPO levels (5.7 mg/L) were reached after 3 days of induction, and the levels declined thereafter (Figure 3 ). Hence, with cells grown in suspension, maximal productivities appear to be reached earlier than in adherent cultures in tissue culture flasks. This is most likely due to decreased cell viability observed after induction of the bioreactor. The fact that the expression levels after extensive cell expansion in the fermentation process were slightly higher than the ones obtained early after transfection suggests that CytTS-OPE vectors are stably maintained and can be used for large-scale production of recombinant proteins. In fact, in this experiment, cells had undergone roughly 14 doublings (a 20,000-fold expansion) from transfection to induction of protein production.
In conclusion, we have generated an episomally replicating SIN/EBVbased hybrid vector that displays tight temperature inducible regulation of gene expression similarly to the parental CytTs vector. However, in contrast to CytTs, this novel vector replicates as an episome and therefore does not require stable integration into the host genome. Our studies with different genes of interest revealed that the expression levels obtained with cell populations were comparable with the ones obtained with selected high producer cell clones transformed with the corresponding parental CytTs vectors. Moreover, the novel vector was successfully used in a perfusion fermentation run. The timelines for large-scale production with CytTs-OPE vectors are essentially reduced to the time required for a fermentation run plus 1 week for the generation of a stable cell population. Hence, this hybrid vector reduces the timelines for large-scale protein production by roughly 3 months, a time routinely needed to generate a stable high producer cell clone. This system will, therefore, be of great value for the rapid production of recombinant proteins.
